Switch View
© PR Newswire
04.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
Investor Lawsuit Targets Replimune (REPL) After FDA Deems RP1 Trial Inadequate - Hagens Berman
News Preview
SAN FRANCISCO, Sept. 4, 2025 /PRNewswire/ -- A new securities class action lawsuit has been filed against Replimune Group, Inc. (NASDAQ: REPL) and its executives. The lawsuit alleges that the company misled investors by overstating the success of its lead cancer drug, RP1, leading to a massive 77% stock price crash after the FDA rejected its appl...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US62856X3008
Q/C Technologies, Inc
QCLS
LISTED
NASDAQ
TNF Pharmaceuticals Announces Closing of $7 Million Private Placement
News Preview
TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”) today announced the closing of a $7.0 million private placement financing of convertible preferred stock with the Company’s largest strategic stockholder and other existing stockholders.
The private placement involved the sale of 7,000 shares of preferred stock, with a stated valu...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: AU000000PME8
Pro Medicus Ltd
PME
LISTED
ASX
Visage Achieves Authority to Operate (ATO) from the U.S. Department of Veterans Affairs
News Preview
Visage receives ATO for the Veterans Affairs Enterprise Cloud (VAEC)
SAN DIEGO, Sept. 4, 2025 /PRNewswire/ -- Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it has been granted an Authority to Operate (ATO) for the Veterans Affairs Enterprise Cloud (VAEC), by the U.S. Department of Veteran...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
04.09.2025
ISIN: US00901B1052
AIM ImmunoTech Inc.
AIMI
LISTED
OTC
AIM ImmunoTech Highlights Growing Body of Compelling Data of Ampligen for the Treatment of Pancreatic Cancer at Conference in Poland
News Preview
Latest progress from lead program Ampligen for the treatment of pancreatic cancer highlighted at the International 5th Annual Marie Skłodowska-Curie Symposium on Cancer Research and Care (MSCI MSCS-2025); Presentation now available here...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
04.09.2025
ISIN: GB00BYMT0J19
LivaNova PLC
LIVN
LISTED
NASDAQ
LivaNova Appoints Donald Zurbay as a New Director
News Preview
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced the appointment of Donald (Don) Zurbay to the Company’s Board of Directors, effective today. Zurbay will serve on the Audit and Compliance Committee for the Board.
“LivaNova is pleased to welcome Don to our Board of Directors,” said William Kozy, Chair of the Boa...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US98420P3082
Xtant Medical Holdings, Inc.
XTNT
LISTED
XASE
Xtant Medical to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
BELGRADE, Mont., Sept. 4, 2025 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and woundcare disorders, today announced that Sean Browne, CEO, and Scott Neils, CFO, will be participating in the H.C. Wainwright 27th Annual...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: CA00143Y1034
AI-ML Innovations Inc.
AIML
LISTED
CSE
Canadian Investment Regulatory Organization Trade Resumption - AIML
News Preview
VANCOUVER, BC, Sept. 4, 2025 /CNW/ - Trading resumes in:
Company: AI-ML Innovations Inc.
CSE Symbol: AIML
All Issues: Yes
Resumption (ET): 9:00 AM
CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the n...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: IL0011809592
NeuroSense Therapeutics Ltd.
NRSN
LISTED
NASDAQ
NeuroSense Therapeutics Announces $500,000 Private Placement at Premium to Market Price
News Preview
Financing at 40% premium to market price provides near-term bridge to anticipated milestones
CAMBRIDGE, Mass., Sept. 4, 2025 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced it has entered into...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: VGG111961055
Biohaven Ltd.
BHVN
LISTED
NYSE
Contact The Gross Law Firm by September 12, 2025 Deadline to Join Class Action Against Biohaven Ltd.(BHVN)
News Preview
NEW YORK, Sept. 4, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Biohaven Ltd. (NYSE: BHVN).
Shareholders who purchased shares of BHVN during the class period listed are encouraged to contac...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Appoints Dr. Christopher W. DiGiovanni to Scientific Advisory Board
News Preview
Bioretec Ltd Press Release 4 September 2025 at 3 p.m. EET
TAMPERE, Finland, Sept. 4, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in bioresorbable orthopedic implants, today announced the appointment of Dr. Christopher W. DiGiovanni to its Scientific Advisory Board (SAB).
Dr. DiGiovanni is an internationally recognized foot and ankle surgeon wh...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Shareholders that lost money on Centene Corporation(CNC) should contact The Gross Law Firm about pending Class Action - CNC
News Preview
NEW YORK, Sept. 4, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Centene Corporation (NYSE: CNC).
Shareholders who purchased shares of CNC during the class period listed are encouraged to co...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US02157Q1094
Alto Neuroscience, Inc.
ANRO
LISTED
NYSE
Alto Neuroscience, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - ANRO
News Preview
NEW YORK, Sept. 4, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO).
Shareholders who purchased shares of ANRO during the class period listed are encouraged...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
04.09.2025
ISIN: US6404911066
Neogen Corp
NEOG
LISTED
NASDAQ
Investors in Neogen Corporation Should Contact The Gross Law Firm Before September 16, 2025 to Discuss Your Rights - NEOG
News Preview
NEW YORK, Sept. 4, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Neogen Corporation (NASDAQ: NEOG).
Shareholders who purchased shares of NEOG during the class period listed are encouraged to...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US76029N1063
Replimune Group Inc
REPL
LISTED
NASDAQ
September 22, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against REPL
News Preview
NEW YORK, Sept. 4, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. (NASDAQ: REPL).
Shareholders who purchased shares of REPL during the class period listed are encouraged...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in RxSight, Inc. Lawsuit - RXST
News Preview
NEW YORK, Sept. 4, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of RxSight, Inc. (NASDAQ: RXST).
Shareholders who purchased shares of RXST during the class period listed are encouraged to cont...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US14070B1017
Capricor Therapeutics, Inc.
CAPR
LISTED
NASDAQ
CAPR LAWSUIT ALERT: The Gross Law Firm Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
News Preview
NEW YORK, Sept. 4, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Capricor Therapeutics, Inc. (NASDAQ: CAPR).
Shareholders who purchased shares of CAPR during the class period listed are enco...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US02155H2004
Altimmune Inc
ALT
LISTED
NASDAQ
Lost Money on Altimmune, Inc.(ALT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm
News Preview
NEW YORK, Sept. 4, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Altimmune, Inc. (NASDAQ: ALT).
Shareholders who purchased shares of ALT during the class period listed are encouraged to cont...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
Shareholders that lost money on Unicycive Therapeutics, Inc.(UNCY) should contact The Gross Law Firm about pending Class Action - UNCY
News Preview
NEW YORK, Sept. 4, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Unicycive Therapeutics, Inc. (NASDAQ: UNCY).
Shareholders who purchased shares of UNCY during the class period listed are enc...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US69120X2062
Owlet Inc
OWLT
LISTED
NYSE
Owlet Extends Global Reach with Launch of Medically-Certified Dream Sock™ to South Africa
News Preview
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, announces the launch of medically-certified Dream Sock™ in South Africa. Distributed as a Class C Medical Device with CE Marking, this groundbreaking product enables parents to track Baby’s live vital signs and receive real-time health notifications, deliv...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: FI4000480454
Bioretec Oy
BRETEC
LISTED
HEL
Bioretec Appoints Dr. Christopher W. DiGiovanni to Scientific Advisory Board
News Preview
Bioretec Ltd Press Release 4 September 2025 at 3 p.m. EET
TAMPERE, Finland, Sept. 4, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in bioresorbable orthopedic implants, today announced the appointment of Dr. Christopher W. DiGiovanni to its Scientific Advisory Board (SAB).
Dr. DiGiovanni is an internationally recognized foot and ankle surgeon wh...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US88023B1035
Tempus AI, Inc.
TEM
LISTED
NASDAQ
Northwestern Medicine Becomes First Health System to Integrate Tempus’ Generative AI Co-Pilot, David, Into Its EHR Platform
News Preview
Northwestern Medicine and Tempus AI, Inc. (NASDAQ: TEM) today announced a notable expansion of their longstanding collaboration. Northwestern Medicine will be the first health system to integrate David, Tempus’ generative-AI clinical co-pilot, within its electronic health record (EHR) platform for its clinical care team. The expanded collaboration...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Tandem t:slim Mobile App Now Authorized by Health Canada for iPhone and Android Phones
News Preview
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced Health Canada authorization for distribution of the Tandem t:slim mobile application for Android and iPhone users. The Tandem t:slim mobile app allows users to deliver a bolus from their compatible smartphone, and to wirelessly up...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US74051N1028
Premier Inc
PINC
LISTED
NASDAQ
Premier, Inc. to Participate in Baird Global Healthcare Conference on September 9, 2025
News Preview
Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that members of its management team will participate in a fireside chat at the Baird Global Healthcare Conference on Tuesday, Sept. 9, 2025 at 8:30 a.m. ET.
A link to the live audio webcast, as well as a replay of this event, will be availab...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
Gilead Sciences Launches Choose U™ Campaign Spotlighting the Inspiring Experiences of People Living with HIV
News Preview
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the launch of Choose U™, a new campaign that spotlights the multifaceted experiences of people living with HIV globally. The timing of the campaign launch coincides with the convening of the 2025 United States Conference on HIV/AIDS (USCHA) taking place September 4-7 in Washington DC, which will...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: GB00BN455J50
Worldwide Healthcare Trust PLC
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLCLEI: 5493003YBCY4W1IMJU04NET ASSET VALUEThe estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for Worldwide Healthcare Trust PLC at the close of business on 3 September 2025 was 363.23p (cum income). ...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: CA00143Y1034
AI-ML Innovations Inc.
AIML
LISTED
CSE
Canadian Investment Regulatory Organization Trading Halt - AIML
News Preview
VANCOUVER, BC, Sept. 4, 2025 /CNW/ - The following issues have been halted by CIRO:
Company: AI-ML Innovations Inc.
CSE Symbol: AIML
All Issues: Yes
Reason: Pending News
Halt Time (ET): 8:15 AM
CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US44148G2049
Hoth Therapeutics, Inc.
HOTH
LISTED
NASDAQ
Hoth Therapeutics Taps Lantern Pharma's PredictBBB.ai Platform -- Breakthrough AI With 94% Accuracy Driving Next-Gen Drug Development
News Preview
NEW YORK, Sept. 4, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, today announced that it is leveraging Lantern Pharma's breakthrough PredictBBB.ai™ platform, a next-generation artificial intelligence (AI) tool with 94% accuracy in predicting blood-brain barrier permeability. This adopti...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: CA16106R1091
Charlotte's Web Holdings Inc
CWEB
LISTED
TSX
Charlotte's Web Announces Plans to Establish a Scientific Advisory Board
News Preview
Scientific Advisory Board to Strengthen Medical Channel Strategy and Accelerate R&D Initiatives
LOUISVILLE, Colo., Sept. 4, 2025 /PRNewswire/ - (TSX: CWEB) (OTCQB: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the pioneer and market leader in hemp-derived CBD wellness, has announced the development of a Scienti...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: CA16106R1091
Charlotte's Web Holdings Inc
CWEB
LISTED
TSX
Charlotte's Web Announces Plans to Establish a Scientific Advisory Board
News Preview
Scientific Advisory Board to Strengthen Medical Channel Strategy and Accelerate R&D Initiatives
LOUISVILLE, Colo., Sept. 4, 2025 /CNW/ - (TSX: CWEB) (OTCQB: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the pioneer and market leader in hemp-derived CBD wellness, has announced the development of a Scientific Adv...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US40131M1099
Guardant Health Inc
GH
LISTED
NASDAQ
Guardant Health Announces Clinical Result Update for Shield Blood-Based Colorectal Cancer Screening Test
News Preview
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a positive clinical readout update assessing the performance of the latest colorectal cancer (CRC) screening algorithm (V2) for its Shield™ blood test. The study met all primary endpoints and the sensitivity of this new screening algorithm for detecting CRC w...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: CA98402E2069
Xebra Brands
XBRA
LISTED
CSE
Canadian Investment Regulatory Organization Trading Halt - XBRA
News Preview
VANCOUVER, BC, Sept. 4, 2025 /CNW/ - The following issues have been halted by CIRO:
Company: XEBRA Brands Ltd.
CSE Symbol: XBRA
All Issues: Yes
Reason: Cease Trade Order
Halt Time (ET): 7:41 AM
CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to...
Themefolio
Profiler
Peergroup
© Newsfile
04.09.2025
ISIN: CA75671E1097
Red Light Holland Corp.
TRIP
LISTED
CSE
Red Light Holland's Wholly Owned Subsidiary Happy Caps Mushroom Farm Secures Continued Safeway Partnership to 123 Stores Across Two Seasonal Programs in the U.S.
News Preview
Toronto, Ontario--(Newsfile Corp. - September 4, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a company engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe, is pleased to announce its secured an expansion milestone...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US6700021040
Novavax Inc
NVAX
LISTED
NASDAQ
Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment
News Preview
GAITHERSBURG, Md., Sept. 4, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced a milestone payment* from Takeda has been triggered by regulatory approval for Novavax's COVID-19 vaccine Nuvaxovid® Intramuscular Injection 1 mL formulated to target SARS-CoV-2 Omicron LP.8.1 as an initial immunization (first and second vaccination) for...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US22407B1089
Coya Therapeutics, Inc.
COYA
LISTED
NASDAQ
Coya Therapeutics' COYA 302 ALS Trial Accepted by NEALS as a NEALS-Affiliated Trial
News Preview
NEALS, the world's largest ALS research consortium, has selected the COYA 302 trial and it is now affiliated with NEALS as part of its mission to accelerate the development of new treatments for people living with ALS;
Following FDA's recent acceptance of the COYA 302 IND, Coya plans to initiate its Phase 2 study in people with ALS in Q4 2025;
Th...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: IE0005711209
ICON PLC
ICLR
LISTED
NASDAQ
ICON Announces CEO Transition
News Preview
ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced that Dr. Steve Cutler has informed the Board of his decision to retire as Chief Executive Officer and the Board has appointed Mr. Barry Balfe, ICON’s Chief Operating Officer, to succeed Dr. Cutler as Chief Executive Officer effective 1 October 2025. Mr. Balfe...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: CH1384053976
NLS Pharmaceutics AG
NLSP
LISTED
NASDAQ
NLS Pharmaceutics and Kadimastem announce a Hong Kong Patent Covering Cell-Selection and Enrichment Technology for IsletRx for Diabetes Patients
News Preview
Patent grant broadens IP protection in Asia and complements prior patents in Europe, the United States and IndiaHong Kong represents a meaningful diabetes market and a critical gateway into Mainland China—including the Greater Bay Area—supporting future clinical collaboration, partnering and commercialization paths for IsletRxZURICH, Sept. 4, 20...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: KYG1281K1067
Silexion Therapeutics Corp
SLXN
LISTED
NASDAQ
Silexion Therapeutics Announces Selection of Contract Research Organization to Support Upcoming Phase 2/3 Clinical Trials for SIL204
News Preview
Strategic CRO to Support Path to Phase 2/3 Trials Following Recently Demonstrated Groundbreaking 97% Inhibition Rates for SIL204...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: CA92767B1058
Vireo Growth Inc
VREO
LISTED
CSE
Vireo Growth Inc. Comments on Recent Market Activity; Company Unaware of Any Material Change
News Preview
MINNEAPOLIS , Sept. 04, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), at the request of the Canadian Investment Regulatory Organization (“CIRO”), today confirmed that Company management is unaware of any material change in the Company’s operations that would account for the recent increase in mar...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: LU2458332611
Alvotech SA
ALVO
LISTED
ICE
Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York
News Preview
REYKJAVIK, Iceland, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference, which will be held in New York, NY, September 8-1...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: LU2458332611
Alvotech SA
ALVO
LISTED
ICE
Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York
News Preview
REYKJAVIK, Iceland, June 4, 2025 - Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference, which will be held in New York, NY, September 8-10, 2025. Alvotech will...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals to Provide Operational Update and Fiscal Quarter Financial Results on September 11, 2025
News Preview
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the company will host a live webcast at 8:30 a.m. ET on Thursday, September 11, 2025 to provide an operational update and release financial results for the fiscal quarter ended July 31, 2025.
The webcast can be accessed on the Investors section of the Company’s website at Kalvis...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2025
ISIN: US04216R1023
Armata Pharmaceuticals, Inc.
ARMP
LISTED
XASE
Armata Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
LOS ANGELES, Sept. 4, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, today annou...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US74039M3097
Predictive Oncology Inc.
POAI
LISTED
NASDAQ
Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients
News Preview
Collaboration builds upon positive results utilizing Predictive Oncology’s AI platform to identify new indications for existing drugs Collaboration builds upon positive results utilizing Predictive Oncology’s AI platform to identify new indications for existing drugs...
Themefolio
Profiler
Peergroup
© Newsfile
04.09.2025
ISIN: US49721T3095
Kiora Pharmaceuticals, Inc.
KPRX
LISTED
NASDAQ
Kiora Pharmaceuticals to Webcast On-Demand Presentation at The H.C. Wainwright 27th Annual Global Investment Conference
News Preview
Encinitas, California--(Newsfile Corp. - September 4, 2025) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) today announced that its Chief Financial Officer, Melissa Tosca, CPA, will showcase the Company's pipeline of therapies targeting inherited and inflammatory retinal diseases at the H.C. Wainwright 27th Annual Global Investment Conference.Present...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the compensation committee of KalVista’s board of directors granted two newly-hired employees inducement options to purchase an aggregate of 5,000 shares of KalVista common stock on September 1, 2025 as inducements material to each employee entering into employment with KalVista....
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US74587B1017
Pulse Biosciences Inc
PLSE
LISTED
NASDAQ
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to two new employees as equity inducement awards outside of the Company's 2017 Equity Inc...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US69608A1088
Palantir Technologies, Inc.
PLTR
LISTED
NASDAQ
Palantir and Lear Announce Five-Year Partnership Expansion to Accelerate Automotive Technology Transformation
News Preview
Palantir Technologies Inc. (NASDAQ: PLTR), a leading provider of AI software, today announced a five-year expansion of its partnership with Lear Corporation (NYSE: LEA), a global automotive leader in Seating and E-Systems. Under the new agreement, Lear will broaden its use of Palantir Foundry, as well as Palantir’s Warp Speed manufacturing operati...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US69608A1088
Palantir Technologies, Inc.
PLTR
LISTED
NASDAQ
Palantir and Lumen Technologies Join Forces to Accelerate AI-Driven Telecom Transformation
News Preview
Palantir Technologies Inc. (NASDAQ: PLTR), a leading provider of enterprise operating systems, and Lumen Technologies (NYSE: LUMN), the trusted network for AI, today announced a collaboration that brings Palantir’s Foundry and Artificial Intelligence Platform (AIP) to Lumen as it transforms its business.
Lumen is transforming from traditional te...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
ISIN: US69608A1088
Palantir Technologies, Inc.
PLTR
LISTED
NASDAQ
A New Set of Palantir Customers Takes the Spotlight at AIPCon 8
News Preview
Palantir Technologies Inc. (NASDAQ: PLTR) announced today that it will host its eighth AIPCon on Thursday, September 4th, 2025, with exclusive content available for online viewers starting 20 minutes before the start of the livestream.
AIPCon 8 will feature 70+ speakers from across its U.S. commercial customer base, many of whom have not previou...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US04301G1022
Artelo Biosciences, Inc.
ARTL
LISTED
NASDAQ
Artelo Biosciences Announces Pricing of $3.0 Million Public Offering
News Preview
SOLANA BEACH, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, or neurological conditions, today announced the pricing of its previously announced underw...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US6283411097
Oncotelic Therapeutics, Inc.
OTLC
LISTED
OTC
Dr. Vuong Trieu, Developer of Novel Oncology and Immunotherapy Assets, Leads Oncotelic Therapeutics’ Commitment to Innovation, Life-Saving Therapies
News Preview
Dr. Trieu’s prolific career includes multibillion-dollar drug discoveries targeting cancers of the breast, pancreas and non-small cell lung cancer, among others...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US8006771062
Sangamo Therapeutics Inc
SGMO
LISTED
NASDAQ
Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at International Congress of Inborn Errors of Metabolism 2025
News Preview
SANGAMO THERAPEUTICS PRESENTS DETAILED DATA FROM REGISTRATIONAL STAAR STUDY IN FABRY DISEASE AT INTERNATIONAL CONGRESS OF INBORN ERRORS OF METABOLISM 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US4327051011
Hillstream BioPharma, Inc.
HILS
LISTED
NASDAQ
Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl
News Preview
RED BANK, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Tharimmune, Inc. (Nasdaq: THAR), a clinical-stage biotechnology company dedicated to developing innovative therapeutic candidates for inflammation, immunology, and critical unmet medical needs announced that management will be participating in three upcoming Fall conferences....
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US1717571079
Cidara Therapeutics, Inc.
CDTX
LISTED
NASDAQ
Cidara Therapeutics to Participate in September Investor Conferences
News Preview
SAN DIEGO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that company management will participate in the below September investor conferences....
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US28531P1030
electroCore, Inc.
ECOR
LISTED
NASDAQ
electroCore Partners with iHeartRadio and Former New York Jets Star Linebacker Greg Buttle to Champion Better Sleep and Stress Relief
News Preview
ROCKAWAY, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today its partnership with Greg Buttle, former New York Jets linebacker and NFL star, to help raise awareness of Truvaga™ Plus, the Company’s next-generation handheld vagus nerve stimulatio...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US55287L1017
MBX Biosciences, Inc.
MBX
LISTED
NASDAQ
MBX Biosciences Doses First Participant in Phase 1 Trial of MBX 4291 for the Treatment of Obesity
News Preview
Preclinical data support the potential for improved weight loss and tolerability with once-monthly administration of MBX 4291 Preclinical data support the potential for improved weight loss and tolerability with once-monthly administration of MBX 4291...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US01625V1044
Alignment Healthcare Inc
ALHC
LISTED
NASDAQ
Alignment Health Earns Spot on Newsweek’s World’s Most Trustworthy Companies 2025 List for Third Consecutive Year
News Preview
Global recognition highlights the company’s leadership in quality, member satisfaction and long-term growth Global recognition highlights the company’s leadership in quality, member satisfaction and long-term growth...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US00439U1043
Grace Therapeutics, Inc.
GRCE
LISTED
NASDAQ
Grace Therapeutics Announces Presentation at The H.C. Wainwright 27th Annual Global Investment Conference
News Preview
PRINCETON, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed for IV infusion to address significant unmet medical needs in aSAH patients, today announc...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US15687V1098
Certara Inc
CERT
LISTED
NASDAQ
Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster
News Preview
Certara today announced the availability of Pinnacle 21 Enterprise Plus, the gold-standard clinical data validation engine....
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2025
ISIN: US2075231017
Connect Biopharma Holdings Ltd
CNTB
LISTED
NASDAQ
Connect Biopharma Announces Two Presentations at the European Respiratory Society (ERS) Congress 2025
News Preview
SAN DIEGO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today announced two poster presentations at the European Respiratory Society (ERS) Congress...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
